KPV 10 mg
Research PeptideKPV (Lys-Pro-Val) 10 mg x 10 vials — Research-Grade Anti-Inflammatory Tripeptide
Document ID: HKPW-kpv-10-mg-laboratory-grade-compounds-v1.0 | Reviewed: HKPEPTIDE WORLDWIDE Research Team | Updated: 2026-08-08
Product Identity & Specifications
| Parameter | Specification |
|---|---|
| Product | KPV (Lys-Pro-Val) |
| Dosage | 10 mg x 10 vials |
| CAS | — |
| Formula | C16H29N5O4 |
| MW | ~343.4 Da |
| Sequence | H-Lys-Pro-Val-OH |
| Purity | ≥99% HPLC |
| Appearance | White to off-white lyophilized powder |
| Solubility | Sterile water or bacteriostatic water |
| Storage | 2–8°C, desiccated, protected from light |
| Class | Anti-Inflammatory Tripeptide |
Research Background
KPV is the C-terminal tripeptide of alpha-MSH that retains anti-inflammatory activity without MC1R-mediated pigmentary effects.
The 10 mg x 10 vials configuration is manufactured under strict quality control with HPLC, MS, and AAA verification. Batch-specific COA included. Bulk and OEM configurations available.
Molecular Mechanisms
NF-kB Suppression
Inhibits NF-kB nuclear translocation reducing TNF-alpha, IL-1beta, IL-6 production.
MAPK Pathway Inhibition
Inhibits p38 MAPK phosphorylation reducing inflammatory mediator production.
Research Applications
- Anti-Inflammatory Signaling Research
- NF-kB Pathway Studies
- Inflammatory Bowel Disease Models
Comparative Analysis
Compared to alpha-MSH: KPV provides anti-inflammatory activity without MC1R-mediated melanogenesis. Compared to BPC-157: KPV targets NF-kB/MAPK inflammatory signaling; BPC-157 targets angiogenesis and cytoprotection.
Quality Specifications
| Parameter | Method | Specification |
|---|---|---|
| Purity | HPLC 214nm C18 | ≥99.0% |
| Identity | ESI-MS | ~343.4 Da |
| Appearance | Visual | White to off-white powder |
| Peptide Content | AAA | ≥80% net peptide |
| Moisture | Karl Fischer | ≤3% |
| Endotoxin | LAL | ≤0.5 EU/mg |
Available Configurations
| Configuration | Content | Best For |
|---|---|---|
| Standard Kit | 10 mg x 10 vials × 10 vials | Evaluation |
| Bulk Kit | Custom × 10 vials | Chronic studies |
| OEM | Custom | Branded products |
FAQ
Q: How is KPV related to alpha-MSH?
KPV is the C-terminal tripeptide (Lys-Pro-Val) that retains alpha-MSH anti-inflammatory activity without MC1R binding and pigmentary effects.
Q: What is KPVs mechanism?
NF-kB suppression reduces pro-inflammatory cytokines. p38 MAPK inhibition reduces inflammatory mediators. KPV distills alpha-MSH anti-inflammatory activity into a minimal tripeptide.
Wholesale Pricing
| Volume | Discount | For |
|---|---|---|
| 1 kit | List price | Evaluation; competitive analysis |
| 5+ kits | 10% off | Initial portfolio expansion |
| 20+ kits | 20% off | Mid-size distributors |
| 50+ kits | 30% off | Regional distributors |
Related Research & Resources
| Resource | Description |
|---|---|
| Healing Regenerative Peptides Hub | Complete research overview & methodology hub |
| Kpv 10 Mg Anti Inflammatory Research Pep | Related research peptide product |
| Kpv 10 Mg Laboratory Grade Compounds | Related research peptide product |
| Why Anti Aging Peptide Research Is Growing Rapidly | Latest research insights & methodology |
View Complete Research Guide »
Compliance
FOR LABORATORY RESEARCH USE ONLY. Not for human or veterinary use. Not a dietary supplement or pharmaceutical.
© 2026 HKPEPTIDE WORLDWIDE. Document ID: HKPW-kpv-10-mg-laboratory-grade-compounds-v1.0